Clinical Trial Update: Study to Evaluate the Long-Term Safety of PA32540 in Subjects Who Are at Risk for Developing Aspirin-Associated Gastric Ulcers [Phase 3]

View source ↗

Summary

This Phase 3 long-term safety study of PA32540 in individuals at risk for aspirin-associated gastric ulcers has completed; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-associated Gastric Ulcers

Drugs mentioned

• PA32540 (aspirin/omeprazole)

Snippet

Sponsor: POZEN | Conditions: Aspirin-Associated Gastric Ulcers | Phase 3 | Status: COMPLETED | Results posted: 2016-02-17